MPR Weekly Dose Podcast Episode 26

from MPR Weekly Dose · host MPR Weekly Dose

This week we talk about a phase 1 vaccine trial for COVID-19 underway in Seattle; Concerns over COVID-19 and ACE inhibitor, ARB use; Safety labeling changes for SGLT2 inhibitors; A biosimilar to Herceptin; And new graphic warnings for cigarette packages.

Episode metadata supplied by the publisher feed · Published Mar 20, 2020

Embed this episode

Attribution link and audio player

Ready to play

MPR Weekly Dose Podcast Episode 26

0:00 5:19

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of MPR Weekly Dose?

This episode is 5 minutes long.

When was this MPR Weekly Dose episode published?

This episode was published on March 20, 2020.

Can I download this MPR Weekly Dose episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!